Identification of a subset of microsatellite-stable endometrial carcinoma with high PD-L1 expression and tumor-associated lymphocytes: A potential strategy for immune checkpoint blockade

MLA

Bryan Fellman, et al. “Identification of a Subset of Microsatellite-Stable Endometrial Carcinoma with High PD-L1 Expression and Tumor-Associated Lymphocytes: A Potential Strategy for Immune Checkpoint Blockade.” Gynecologic Oncology, vol. 154, June 2019, pp. 249–50. EBSCOhost, https://doi.org/10.1016/j.ygyno.2019.04.575.

APA

Bryan Fellman, S. Crumley, Russell Broaddus, & Monica Avila. (2019). Identification of a subset of microsatellite-stable endometrial carcinoma with high PD-L1 expression and tumor-associated lymphocytes: A potential strategy for immune checkpoint blockade. Gynecologic Oncology, 154, 249–250. https://doi.org/10.1016/j.ygyno.2019.04.575

Chicago

Bryan Fellman, S. Crumley, Russell Broaddus, and Monica Avila. 2019. “Identification of a Subset of Microsatellite-Stable Endometrial Carcinoma with High PD-L1 Expression and Tumor-Associated Lymphocytes: A Potential Strategy for Immune Checkpoint Blockade.” Gynecologic Oncology 154 (June): 249–50. doi:10.1016/j.ygyno.2019.04.575.